I agree that this site is using cookies. You can find further informations here.
X
Gris-Oliver, Albert
51  results:
Search for persons X
?
1

FRI-467 Efficacy of WNTinib, a novel selective therapeutic ..:

Balaseviciute, Ugne ; Abril-Fornaguera, Jordi ; Huguet-Pradell, Júlia...
Journal of Hepatology.  80 (2024)  - p. S417-S418 , 2024
Link: https://doi.org/10.1016/..
 
?
2

TOP-507-YI Single-cell RNA sequencing-derived gene signatur..:

Cappuyns, Sarah ; Piqué-Gili, Marta ; Esteban-Fabró, Roger...
Journal of Hepatology.  80 (2024)  - p. S411-S412 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Identification of a Molecularly-Defined Subset of Breast an..:

Serra, Violeta ; Wang, Anderson T. ; Castroviejo-Bermejo, Marta...
Clinical Cancer Research.  28 (2022)  20 - p. 4536-4550 , 2022
Link: https://doi.org/10.1158/..
 
?
4

AKT-mTORC1 reactivation is the dominant resistance driver f..:

Dunn, Shanade ; Eberlein, Cath ; Yu, Jason...
Oncogene.  41 (2022)  46 - p. 5046-5060 , 2022
Link: https://doi.org/10.1038/..
 
?
5

GDF15 Is an Eribulin Response Biomarker also Required for S..:

Bellio, Chiara ; Emperador, Marta ; Castellano, Pol...
Cancers.  14 (2022)  10 - p. 2562 , 2022
Link: https://doi.org/10.3390/..
 
?
6

PI3K activation promotes resistance to eribulin in HER2-neg..:

Gris-Oliver, Albert ; Ibrahim, Yasir H. ; Rivas, Martín A....
British Journal of Cancer.  124 (2021)  9 - p. 1581-1591 , 2021
Link: https://doi.org/10.1038/..
 
?
7

Ascorbic acid supports ex vivo generation of plasmacytoid d..:

Laustsen, Anders ; van der Sluis, Renée M ; Gris-Oliver, Albert...
eLife.  10 (2021)  - p. , 2021
Link: https://doi.org/10.7554/..
 
?
8

Personalized cancer therapy prioritization based on driver ..:

Mateo, Lidia ; Duran-Frigola, Miquel ; Gris-Oliver, Albert...
Genome Medicine.  12 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
9

In vivo phosphoproteomics reveals kinase activity profiles ..:

Zagorac, Ivana ; Fernandez-Gaitero, Sara ; Penning, Renske...
Nature Communications.  9 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
10

AKT-mTORC1 reactivation is the dominant resistance driver f..:

Dunn, Shanade ; Eberlein, Cath ; Yu, Jason...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652152/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

TLR2 and TLR7 mediate distinct immunopathological and antiv..:

van der Sluis, Renée M ; Cham, Lamin B ; Gris-Oliver, Albert...
https://pure.au.dk/portal/en/publications/dcc6b2ba-9dad-478a-a63e-7bde8ca0308d.  , 2022
Link: https://pure.au.dk/porta..
 
?
12

GDF15 is an Eribulin Response Biomarker also required for S..:

Bellio, Chiara ; Emperador, Marta ; Castellano, Pol...
Reproducció del document publicat a: https://doi.org/10.3390/CANCERS14102562.  , 2022
Link: http://hdl.handle.net/24..
 
?
13

Identification of a Molecularly-Defined Subset of Breast an..:

Serra, Violeta ; Wang, Anderson T ; Castroviejo-Bermejo, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561606/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

Ascorbic acid supports ex vivo generation of plasmacytoid d..:

Laustsen, Anders ; van der Sluis, Renée M ; Gris-Oliver, Albert...
Norges forskningsråd: 223255.  , 2021
Link: https://hdl.handle.net/1..
 
?
15

PI3K activation promotes resistance to eribulin in HER2-neg..:

Gris-Oliver, Albert ; Ibrahim, Yasir H ; Rivas, Martín A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076303/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15